- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2013
- Public Summary Document (PSD) November 2013 PBAC Meeting - PDF
Eribulin mesilate – November 2013
Eribulin mesilate, injection in vial, 1mg/2mL Halaven®
Last updated
8 November 2023